Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,127.88
(
-0.70%
)
News Focus
News Focus
Post# of 824147
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4180
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: SkyLimit2022 post# 580484

Saturday, 04/22/2023 1:22:52 AM

Saturday, April 22, 2023 1:22:52 AM

Post# of 824147
Combo trial for recurrent GBM requires a significant resection to qualify for the trial which significantly improve the odds of survival versus the DCVax-L P3 recurrent GBM arm did not have a resection. Not going to be comparable data.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News